FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Miranda Chakos

Research Profile

Disorders

Chemicals & Drugs

Activities & Behaviors

Schizophrenic Psychology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Miranda Chakos; Ira D Glick; Mark B Hammer; Alexander Miller; Javendra K Patel; Robert Rosenheck; Andre Tapp; Del Miller
Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
Del D Miller; Stanley N Caroff; Sonia M Davis; Robert A Rosenheck; Joseph P McEvoy; Bruce L Saltz; Silvana Riggio; Miranda Chakos; Marvin S Swartz; Richard S E Keefe; Thomas Stroup; Jeffrey A Lieberman
Extrapyramidal side-effects of antipsychotics in a randomised trial.
Miranda Chakos; Ira D Glick; Alexander Miller; Mark B Hamner; Del D Miller; Jayendra K Patel; Andre Tapp; Richard S E Keefe; Robert A Rosenheck
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Miranda Chakos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Miranda Chakos; Ira D Glick; Mark B Hammer; Alexander Miller; Javendra K Patel; Robert Rosenheck; Andre Tapp; Del Miller
Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
Clinical schizophrenia & related psychoses 2011;5(3):124-34.
2008: Del D Miller; Stanley N Caroff; Sonia M Davis; Robert A Rosenheck; Joseph P McEvoy; Bruce L Saltz; Silvana Riggio; Miranda Chakos; Marvin S Swartz; Richard S E Keefe; Thomas Stroup; Jeffrey A Lieberman
Extrapyramidal side-effects of antipsychotics in a randomised trial.
The British journal of psychiatry : the journal of mental science 2008;193(4):279-88.
2006: Miranda Chakos; Ira D Glick; Alexander Miller; Mark B Hamner; Del D Miller; Jayendra K Patel; Andre Tapp; Richard S E Keefe; Robert A Rosenheck
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial.
Psychiatric services (Washington, D.C.) 2006;57(8):1094-101.
2006: Karen A Nolan; Pal Czobor; Leslie Citrome; Menachem Krakowski; Herbert M Lachman; James L Kennedy; Xingqun Ni; Jeffrey Lieberman; Miranda Chakos; Jan Volavka
Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neuroleptics.
Journal of clinical psychopharmacology 2006;26(3):338-40.
2006: Matthew Hoptman; Jan Volavka; Pal Czobor; Guido Gerig; Miranda Chakos; Joseph Blocher; Leslie Citrome; Brian Sheitman; Jean-Pierre Lindenmayer; Jeffrey A Lieberman; Robert Bilder
Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder.
The Journal of neuropsychiatry and clinical neurosciences 2006;18(4):509-15.
2005: Del D Miller; Joseph P McEvoy; Sonia M Davis; Stanley N Caroff; Bruce L Saltz; Miranda Chakos; Marvin S Swartz; Richard S E Keefe; Robert A Rosenheck; Thomas Stroup; Jeffrey A Lieberman
Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.
Schizophrenia research 2005;80(1):33-43.
2005: Jonathan M Meyer; Henry A Nasrallah; Joseph P McEvoy; Donald C Goff; Sonia M Davis; Miranda Chakos; Jayendra K Patel; Richard S E Keefe; Thomas Stroup; Jeffrey A Lieberman
The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.
Schizophrenia research 2005;80(1):9-18.
2005: Matthew Hoptman; Jan Volavka; Elisabeth M Weiss; Pal Czobor; Philip Szeszko; Guido Gerig; Miranda Chakos; Joseph Blocher; Leslie Citrome; Jean-Pierre Lindenmayer; Brian Sheitman; Jeffrey A Lieberman; Robert Bilder
Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder.
Psychiatry research 2005;140(2):133-45.
2005: Miranda Chakos; Scott A Schobel; Hongbin Gu; Guido Gerig; Daniel Bradford; Cecil Charles; Jeffrey A Lieberman
Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia.
The British journal of psychiatry : the journal of mental science 2005;186():26-31.
2004: Jean-Pierre Lindenmayer; Pal Czobor; Jan Volavka; Jeffrey A Lieberman; Leslie Citrome; Brian Sheitman; Joseph P McEvoy; Thomas B Cooper; Miranda Chakos
Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
The Journal of clinical psychiatry 2004;65(4):551-6.
2004: Brian Sheitman; Michael B Knable; L Fredrik Jarskog; Miranda Chakos; Leslie Boyce; John Early; Jeffrey A Lieberman
Secretin for refractory schizophrenia.
Schizophrenia research 2004;66(2-3):177-81.
2004: Rael D Strous; Jose M J Alvir; Delbert Robinson; Gilad Gal; Brian Sheitman; Miranda Chakos; Jeffrey A Lieberman
Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects.
Schizophrenia bulletin 2004;30(2):265-78.
2003: Jean-Pierre Lindenmayer; Pal Czobor; Jan Volavka; Leslie Citrome; Brian Sheitman; Joseph P McEvoy; Thomas B Cooper; Miranda Chakos; Jeffrey A Lieberman
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
The American journal of psychiatry 2003;160(2):290-6.
2002: Jean-Pierre Lindenmayer; Pal Czobor; Jan Volavka; Jeffrey A Lieberman; Leslie Citrome; Brian Sheitman; Miranda Chakos; Joseph P McEvoy
Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
The Journal of clinical psychiatry 2002;63(10):931-5.
2002: Robert Bilder; Jan Volavka; Pal Czobor; Anil Malhotra; James L Kennedy; Xingqun Ni; Robert S Goldman; Matthew Hoptman; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph P McEvoy; Michal Kunz; Miranda Chakos; Thomas B Cooper; Jeffrey A Lieberman
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
Biological psychiatry 2002;52(7):701-7.
2002: Robert Bilder; Robert S Goldman; Jan Volavka; Pal Czobor; Matthew Hoptman; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph McEvoy; Michal Kunz; Miranda Chakos; Thomas B Cooper; Terri L Horowitz; Jeffrey A Lieberman
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
The American journal of psychiatry 2002;159(6):1018-28.
2002: Pal Czobor; Jan Volavka; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph McEvoy; Thomas B Cooper; Miranda Chakos; Jeffrey A Lieberman
Antipsychotic-induced weight gain and therapeutic response: a differential association.
Journal of clinical psychopharmacology 2002;22(3):244-51.
2002: Jan Volavka; Pal Czobor; Brian Sheitman; Jean-Pierre Lindenmayer; Leslie Citrome; Joseph P McEvoy; Thomas B Cooper; Miranda Chakos; Jeffrey A Lieberman
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
The American journal of psychiatry 2002;159(2):255-62.
2001: Jeffrey A Lieberman; Diana O Perkins; Aysenil Belger; Miranda Chakos; F Jarskog; Kalina Boteva; John Gilmore
The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches.
Biological psychiatry 2001;50(11):884-97.
2001: Leslie Citrome; Jan Volavka; Pal Czobor; Brian Sheitman; Jean-Pierre Lindenmayer; Joseph McEvoy; Thomas B Cooper; Miranda Chakos; Jeffrey A Lieberman
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
Psychiatric services (Washington, D.C.) 2001;52(11):1510-4.
2001: Jean-Pierre Lindenmayer; Jan Volavka; J Lieberman; Brian Sheitman; Leslie Citrome; Miranda Chakos; Pal Czobor; B Parker; Adel Iskander
Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial.
Journal of clinical psychopharmacology 2001;21(4):448-53.
2001: Miranda Chakos; Jeffrey Lieberman; E Hoffman; D Bradford; Brian Sheitman
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
The American journal of psychiatry 2001;158(4):518-26.
2001: Jeffrey Lieberman; Miranda Chakos; H Wu; Jose Alvir; E Hoffman; Delbert Robinson; Robert Bilder
Longitudinal study of brain morphology in first episode schizophrenia.
Biological psychiatry 2001;49(6):487-99.
2000: Brian Sheitman; M G Murray; J A Snyder; S Silva; R Goldman; Miranda Chakos; Jan Volavka; Jeffrey A Lieberman
IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness.
Schizophrenia research 2000;46(2-3):203-7.
1999: Delbert Robinson; Margaret G Woerner; Jose Alvir; S Geisler; AR Koreen; Brian Sheitman; Miranda Chakos; David Mayerhoff; Robert Bilder; R Goldman; Jeffrey A Lieberman
Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.
The American journal of psychiatry 1999;156(4):544-9.
1999: Delbert Robinson; Margaret G Woerner; Jose Alvir; Robert Bilder; R Goldman; S Geisler; AR Koreen; Brian Sheitman; Miranda Chakos; David Mayerhoff; Jeffrey A Lieberman
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.
Archives of general psychiatry 1999;56(3):241-7.
1999: H Lee; FI Tarazi; Miranda Chakos; H Wu; M Redmond; Jose Alvir; B J Kinon; Robert Bilder; I Creese; Jeffrey A Lieberman
Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum.
Life sciences 1999;64(18):1595-602.
1998: Jeffrey A Lieberman; Richard B Mailman; Gary E Duncan; Linmarie Sikich; Miranda Chakos; David E Nichols; John E Kraus
Serotonergic basis of antipsychotic drug effects in schizophrenia.
Biological psychiatry 1998;44(11):1099-117.
1998: Miranda Chakos; O Shirakawa; Jeffrey Lieberman; H Lee; R Bilder; Carol A Tamminga
Striatal enlargement in rats chronically treated with neuroleptic.
Biological psychiatry 1998;44(8):675-84.
1998: Jeffrey A Lieberman; Brian Sheitman; Miranda Chakos; Delbert Robinson; N Schooler; S Keith
The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective.
Journal of clinical psychopharmacology 1998;18(2 Suppl 1):20S-4S.
1998: C Andersson; Miranda Chakos; Richard B Mailman; J Lieberman
Emerging roles for novel antipsychotic medications in the treatment of schizophrenia.
The Psychiatric clinics of North America 1998;21(1):151-79.
1998: Miranda Chakos; S Esposito; Cecil Charles; Jeffrey A Lieberman
Clinical applications of neuroimaging in psychiatry.
Magnetic resonance imaging clinics of North America 1998;6(1):155-64.
1997: AR Koreen; Jeffrey A Lieberman; Jose Alvir; Miranda Chakos
The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controls.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(1):61-8.
1996: Miranda Chakos; Jose Alvir; Margaret G Woerner; A Koreen; S Geisler; David Mayerhoff; S Sobel; John M Kane; Michael Borenstein; Jeffrey A Lieberman
Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.
Archives of general psychiatry 1996;53(4):313-9.
1996: Jeffrey A Lieberman; Jose Alvir; A Koreen; S Geisler; Miranda Chakos; Brian Sheitman; Margaret G Woerner
Psychobiologic correlates of treatment response in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;14(3 Suppl):13S-21S.
1996: Jeffrey A Lieberman; A R Koreen; Miranda Chakos; Brian Sheitman; Margaret G Woerner; Jose Alvir; Robert Bilder
Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia.
The Journal of clinical psychiatry 1996;57 Suppl 9():5-9.
1995: A Chatterjee; Miranda Chakos; A Koreen; S Geisler; Brian Sheitman; Margaret G Woerner; John M Kane; Jose Alvir; Jeffrey A Lieberman
Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.
The American journal of psychiatry 1995;152(12):1724-9.
1995: S Szymanski; Jeffrey A Lieberman; Jose Alvir; David Mayerhoff; A Loebel; S Geisler; Miranda Chakos; A Koreen; D Jody; John M Kane
Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
The American journal of psychiatry 1995;152(5):698-703.
1995: Miranda Chakos; Jeffrey A Lieberman; Jose Alvir; Robert Bilder; Manzar Ashtari
Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine.
Lancet 1995;345(8947):456-7.
1995: S Szymanski; J Lieberman; Simcha Pollack; A Safferman; R Munne; D Umbricht; John M Kane; M Kronig; Miranda Chakos; T Cooper
Clozapine effects on neuroendocrine response to apomorphine challenge testing in chronic neuroleptic nonresponsive schizophrenia: preliminary findings.
Biological psychiatry 1995;37(1):52-5.
1994: J S Aronowitz; Miranda Chakos; A Z Safferman; Jeffrey A Lieberman
Syncope associated with the combination of clozapine and enalapril.
Journal of clinical psychopharmacology 1994;14(6):429-30.
1994: Miranda Chakos; Jeffrey A Lieberman; Robert Bilder; Michael Borenstein; G Lerner; B Bogerts; H Wu; B Kinon; Manzar Ashtari
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.
The American journal of psychiatry 1994;151(10):1430-6.
1994: Robert Bilder; H Wu; Miranda Chakos; B Bogerts; Simcha Pollack; J Aronowitz; Manzar Ashtari; G Degreef; John M Kane; Jeffrey A Lieberman
Cerebral morphometry and clozapine treatment in schizophrenia.
The Journal of clinical psychiatry 1994;55 Suppl B():53-6.
1994: A R Koreen; J Lieberman; Jose Alvir; David Mayerhoff; A Loebel; Miranda Chakos; F Amin; T Cooper
Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.
Archives of general psychiatry 1994;51(2):132-8.
1994: A R Koreen; J Lieberman; Jose Alvir; Miranda Chakos; A Loebel; T Cooper; John M Kane
Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.
The American journal of psychiatry 1994;151(1):35-9.
1993: A R Koreen; Samuel Siris; Miranda Chakos; Jose Alvir; David Mayerhoff; J Lieberman
Depression in first-episode schizophrenia.
The American journal of psychiatry 1993;150(11):1643-8.
1993: B J Kinon; John M Kane; Miranda Chakos; R Munne
Possible predictors of neuroleptic-resistant schizophrenic relapse: influence of negative symptoms and acute extrapyramidal side effects.
Psychopharmacology bulletin 1993;29(3):365-9.
1992: Miranda Chakos; David Mayerhoff; A D Loebel; Jose Alvir; Jeffrey A Lieberman
Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia.
Psychopharmacology bulletin 1992;28(1):81-6.
1991: David Mayerhoff; E Pelta; C Valentino; Miranda Chakos
Real-life basis for a patient's paranoia.
The American journal of psychiatry 1991;148(5):682-3.